Year: 2019 | Month: February | Volume: 9 | Issue: 2 | Pages: 278-286
Understanding the Cost & Outcomes of Pediatric Leukemia in the United States: A Review of Current Literature
Rutgers School of Health Professions, Newark, NJ
The cost associated with healthcare has continually increased over the years mainly for oncologic care and treatment of chronic conditions. These trends have also coincided with increasing closure of community or local governmentally assisted healthcare organizations. These means local care provision for patients with cancer is likely to increase for parents, insurance (Governmental and Private) as well as healthcare organizations. Some studies have evaluated specific leukemia subtypes within healthcare systems. The financial burden associated with diagnosis increased hospitalizations because of stress both physical and psychological on patients and parents. Cost of care varies for patients based on disease severity and mortality risks. The total cost of care and drug costs increased significantly across the country. This paper provides a clearer picture of the diverse factors that impact patient outcome improvement and cost increase. It is imperative to address the coverage gap as well as social support for parents to adequately address the diversity of factors that impact outcomes and cost.
Key words: Leukemia, Lymphoid, Health Outcomes, Cost, Charges, Cost Influencers,